PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Medical Ikkou Group Co.,Ltd.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Medical Ikkou Group Co.,Ltd.'s yearly results (2023–2026), compared with Industrials companies in Japan. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 90% of Industrials companies in Japan.

Where ¥100 of sales goes

¥97Operating costs¥0.2Interest¥2.3Net profit¥0.7Paid as dividends

Latest year (Feb 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

¥194

Over the last 3 years, every ¥100 of reported profit came with ¥194 of operating cash.

Higher than 82% of Industrials companies in Japan.

Self-Funding Ratio

3.5×

Over the last 3 years its own operating cash covered its investment spending (capex) 3.5 times.

Higher than 73% of Industrials companies in Japan.

Cash Locked Ratio

¥8

For every ¥100 of sales, ¥8 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥8 tied up three years earlier.

Less money tied up than 74% of Industrials companies in Japan.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 90% of Industrials companies in Japan.

Growth Efficiency Ratio

¥2

Sales grew 62% in 3 years; of every extra ¥100 of sales, ¥2 became extra profit.

Lower than 76% of Industrials companies in Japan.

Asset Productivity Ratio

+62% / +37%

In 3 years sales changed by +62% while total assets changed by +37%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

0.4×

Debt due within a year is covered 0.4 times by its yearly operating cash.

Lower than 72% of Industrials companies in Japan.

Cash Cushion Ratio

−40%

Debt, after subtracting cash, equals 40% of its market value (net debt).

Lower than 82% of Industrials companies in Japan.

Tangible Assets Ratio

98%

Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 65% of Industrials companies in Japan.

Tangible Net Worth Ratio

94%

Of every ¥100 of net worth, ¥94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 69% of Industrials companies in Japan.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years. Dividends paid equalled 21% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

Medical Ikkou Group Co.,Ltd. owes ¥0.56 for every ¥1 it owns. Net profit rose 13% in the year to Feb 2026, and grew 19% a year on average over 3 years.

Compared with Industrials companies in Japan · latest annual results Feb 2026.

P/E ratio

7.1

Investors pay ¥7.1 for every ¥1 of Medical Ikkou Group Co.,Ltd.'s yearly profit, lower than 91% of Industrials companies in Japan.

P/B ratio

0.65

The share price is 0.65 times Medical Ikkou Group Co.,Ltd.'s book value per share, lower than 79% of Industrials companies in Japan.

Market cap

¥10.4 B

The total market value of all of Medical Ikkou Group Co.,Ltd.'s shares at today's price (share price × number of shares), smaller than 69% of Industrials companies in Japan. PosiCap size class: Micro Cap.

Net worth (book value)

¥16.0 B

What Medical Ikkou Group Co.,Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Aug 2026).

Book value per share

¥4,252

Net worth divided by the number of shares. The share price of ¥2,770 is 0.7 times this, which is the P/B above.

Return on equity (ROE)

9.4%

Medical Ikkou Group Co.,Ltd. earned 9.4% on its shareholders' money over the last year, higher than 53% of Industrials companies in Japan.

Owes vs Owns

0.56×

Medical Ikkou Group Co.,Ltd. owes ¥0.56 for every ¥1 it owns (moderate), higher than 76% of Industrials companies in Japan.

Dividend yield

4.33%

Medical Ikkou Group Co.,Ltd. pays 4.33% of its share price as dividends a year, higher than 80% of dividend-paying Industrials companies in Japan.

Revenue growth

+14%

Revenue rose 14% in the year to Feb 2026, and grew 17% a year on average over 3 years.

Profit growth

+13%

Net profit rose 13% in the year to Feb 2026, and grew 19% a year on average over 3 years.

Profit margin

2.3%

Medical Ikkou Group Co.,Ltd. keeps ¥2 of every ¥100 of revenue as net profit.

Cash quality

0.95×

Cash from Medical Ikkou Group Co.,Ltd.'s business was 0.95× its reported profit in the year to Feb 2026 — less cash came in than the profit reported.

Interest cover

17.4×

Medical Ikkou Group Co.,Ltd.'s operating profit covered its interest costs 17.4 times in the year to Feb 2026.

Cash vs debt

Net debt

Medical Ikkou Group Co.,Ltd. had ¥4.2 B more debt than cash (net debt) at Feb 2026.

Questions

What is Medical Ikkou Group Co.,Ltd.'s P/E ratio?

Investors pay ¥7.1 for every ¥1 of Medical Ikkou Group Co.,Ltd.'s yearly profit, lower than 91% of Industrials companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Medical Ikkou Group Co.,Ltd.: ¥10.4 B ÷ ¥16.0 B (31 Aug 2026) = 0.7.

What is Medical Ikkou Group Co.,Ltd.'s return on equity?

Medical Ikkou Group Co.,Ltd. earned 9.4% on its shareholders' money over the last year, higher than 53% of Industrials companies in Japan.

How much does Medical Ikkou Group Co.,Ltd. owe compared with what it owns?

Medical Ikkou Group Co.,Ltd. owes ¥0.56 for every ¥1 it owns (moderate), higher than 76% of Industrials companies in Japan.

Does Medical Ikkou Group Co.,Ltd. pay a dividend?

Yes. Medical Ikkou Group Co.,Ltd. pays 4.33% of its share price as dividends a year, higher than 80% of dividend-paying Industrials companies in Japan.

Is Medical Ikkou Group Co.,Ltd.'s revenue growing?

Revenue rose 14% in the year to Feb 2026, and grew 17% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.